Sökning: "multiple myeloma"

Visar resultat 21 - 25 av 88 avhandlingar innehållade orden multiple myeloma.

  1. 21. Novel Superantigens for Immunotherapy of Multiple Myeloma

    Författare :Lotten Ragnarsson; Uppsala universitet; []
    Nyckelord :;

    Sammanfattning : .... LÄS MER

  3. 22. Therapeutic potential of natural killer cells in multiple myeloma

    Författare :Evren Alici; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :Natural Killer cells; immunotherapy; multiple myeloma; gene therapy;

    Sammanfattning : Multiple Myeloma (MM) is an incurable plasma cell neoplasm with a median length of survival after diagnosis of approximately three years; therefore new treatment modalities to eradicate the disease are needed. Although the disease remains incurable, current main alternatives are drug treatment modalities and autologous stem cell transplantation (ASCT). LÄS MER

  4. 23. Studies on multiple myeloma in vivo and in vitro

    Författare :Gunilla Brenning; Uppsala universitet; []
    Nyckelord :MEDICINE; MEDICIN;

    Sammanfattning : .... LÄS MER

  5. 24. Natural and induced idiotype immunity in patients with multiple myeloma

    Författare :Lotta Hansson; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :Myeloma; idiotype; vaccination; GM-CSF; IL-12; clonal B cells; T cell epitopes; signal transduction molecules; activation markers;

    Sammanfattning : There is a great need for development of new treatment alternatives for patients with multiple myeloma (MM). The idiotype (Id) immunoglobulin (Ig) expressed by the myeloma B cell clone might be regarded as a tumor specific antigen and as such a target for immunotherapy. LÄS MER

  7. 25. Immunological and clinical long-term effects of idiotype vaccination in multiple myeloma patients

    Författare :Amir Osman Abdalla; Karolinska Institutet; Karolinska Institutet; []
    Nyckelord :Idiotype; vaccination; multiple myeloma; T cell response;

    Sammanfattning : In spite of the promising results shown by new anti-myeloma agents, multiple myeloma (MM) remains incurable and additional therapy to overcome the inevitable disease recurrence is greatly needed. Immunotherapy is currently under evaluation as a novel alternative or complementary therapy in many cancer types. LÄS MER